Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Positive results from clinical trials often give biotechnology companies a boost, but this one was big. Shares of Sana Biotechnology–a firm with a market capitalization of less than $400 million ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.